ATTORNEYS HANDLING CLAIMS AGAINST INVOKANA, JARDIANCE, AND FARXIGA.

SGLT-2 INHIBITOR LAWYERS

Invokana Dangerous Drug Attorneys

SGLT2 inhibitor medicine manufacturers have been sued by people who suffered harm like kidney damage, amputations, and ketoacidosis. The qualified attorneys on our network are experienced attorneys currently actively involved in litigation of claims against manufacturers of diabetic medications called sodium-glucose-co-transporter 2 (or “SGLT2”) inhibitors. These medications are linked to dangerous side effects, including kidney disease, ketoacidosis, and conditions that require amputation. If you are taking an SGLT2 inhibitor to treat your diabetes and develop any of these injuries, contact our attorneys today to find out whether you may have grounds for legal action.

SGLT2 inhibitor medications treat type-2 diabetes. A condition where a person’s pancreas does not produce enough insulin to regulate blood sugar. Individuals diagnosed with type 2 diabetes have too much sugar in their blood. SGLT2 inhibitors are supposed to help patients keep their blood sugar under control if combined with a balanced diet and exercise.

SGLT2 inhibitors work by targeting proteins acting within the renal system: two proteins called the sodium-glucose co-transporters. Typically, your kidneys filter waste out of your body, and SGLT2 protein allows glucose to be reabsorbed and used by your body as fuel. When this SGLT2 protein is inhibited or prevented from acting, your kidneys flush more glucose from your body through urine before it is reabsorbed. By stopping the SGLT2 protein from sending more glucose back into the diabetic person’s bloodstream, SGLT2 inhibitors are meant to help people with diabetes get better control over their sugar levels.

While the drugs containing the SGLT2 inhibitors seem to have incredible benefits, they come with several risks for serious health complications, including complications that can worsen common diabetes problems. Our litigation attorneys are filing lawsuits against the manufacturers of SGLT2 inhibitors because they did not adequately test the drugs before marketing, sold defective drugs to innocent consumers, and failed to adequately warn the medical community about all the risks associated with their medications. SGLT2 inhibitors may cause severe medical conditions, some of which may be life-threatening if not promptly or adequately treated. For example, SGLT2 inhibitors have been linked to severe urinary tract infections, which may require hospitalization, and can cause pyelonephritis (kidney infections) and urosepsis (serious blood infections).

Urine tract infections may start with relatively non-obvious symptoms, such as increased urgency to pee, differences in the smell of urine, or mild pressure when peeing. These symptoms then quickly escalate to an aching, burning pain when urinating, pain in your back or pelvis, and blood in your urine. These are signs the infection is getting worse and maybe reach a kidney-infection level.

Many patients who have developed severe urinary tract infections with SGLT2 inhibitors will continue to have renal or blood diseases, requiring hospitalization treatment. If left untreated, these may cause severe kidney damage or even death. Another risk with SGLT2 inhibitors is diabetic ketoacidosis.

Ketoacidosis is when an individual’s body produces too many ketones, or acids, in the blood. Ketones are acids released when fat is broken down, and this often happens to diabetic patients who lack sufficient insulin to use glucose as energy. Muscles will break down fat instead to get power. If too many ketones are released in the process of breaking down the fat, these could accumulate and result in the dangerous condition known as ketoacidosis.

A blood test can conclusively prove if a patient is experiencing ketoacidosis. Ketoacidosis may lead to abnormal blood sugars, especially troublesome in those who have diabetes, abnormal potassium, and brain swelling. If left untreated, ketoacidosis can result in loss of consciousness and death. In addition, people taking SGLT2 inhibitors are at high risk for developing conditions that require the toes, feet, or even legs to be amputated.

Because diabetic patients often develop narrowed blood vessels and nerve damage (neuropathy), they are susceptible to problems with decreased blood flow in their lower limbs. This may result in ischemia (no blood flowing to a limb or digit) and reduced pain sensation. When diabetic patients experience decreased sensation in the feet, they may struggle to recognize injuries in the feet, such as injuries and ulcers. If blood flow into your feet or toes is cut off entirely, or if the ulcers or wounds are left untreated and infected, your feet and toes tissues may die. At that point, patients may experience necrosis or gangrene, for which amputation is the only treatment.

These complications can occur already in patients with diabetes, but the study found that the SGLT2 inhibitor increased the likelihood of amputation by nearly 50%. The troubling connection between amputations and the use of SGLT2 inhibitors has spurred the FDA’s response, including the imposition of a black box (the strongest warning possible) on at least one brand of an SGLT2 inhibitor. Amputations related to SGLT2 inhibitors are more commonly of the toes or a portion of the feet, but both leg amputations above and below the knee have occurred. All injuries associated with SGLT2 inhibitors are severe in their impact on patients’ lives and their families. Diabetic patients are an already vulnerable population, facing multiple everyday health problems.

They already feel they are constantly fighting a battle to stay healthy. But, then, the very drugs meant to help them end up doing more harm, possibly life-threatening or disabling. Families have lost loved ones due to complications from the SGKT2 inhibitor, and individuals have suffered horrendous amputations, leaving them unable to move, forced to resort to expensive, uncomfortable prosthetics, and unable to do things that they once enjoyed.

Many people have lost jobs, and their lives have been drastically altered by their health conditions and loss of limbs. In addition to the physical aspects of these injuries, families are experiencing huge financial losses and extreme emotional pain. Patients may suffer from PTSD, depression, anxiety, phantom limb phenomena, insomnia, and adverse effects on their relationships with friends and family. Because of the extensive medical bills and loss of income, their families are suddenly stretched thin, trying to make ends meet. Trauma patients also feel the burden of the family’s difficulties.

Can I File a Lawsuit After Taking Invokana?

When you feel you do not have anywhere else to turn after an injury from an SGLT2 inhibitor, you can rely on attorneys from our national network to stand beside you and fight for your rights. You deserve compensation for how you and your family suffered and some peace of mind and stability restored in your life.

Contact our SGLT2 inhibitor attorneys today to learn more about our SGLT2 inhibitor litigation and determine whether you may be eligible to join our lawsuit against the manufacturers.

If you or someone you love has taken an SGLT2 inhibitor and suffered amputation, contact our attorneys at (888) 491-0444 and talk to one of our knowledgeable Dangerous Drug Lawyers about your potential to bring a lawsuit against the manufacturers of this medication.